Related Experiment Videos
Spinal muscular atrophy type 1: A noninvasive respiratory management approach
J R Bach1, V Niranjan, B Weaver
1Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ, USA. bachjr@umdnj.edu
Insights
This study shows that a respiratory muscle aid protocol can help avoid tracheostomy in infants with spinal muscular atrophy type 1, improving extubation success rates. This approach allows for home management with nasal ventilation.
Area of Science:
- Pediatric Pulmonology
- Neuromuscular Disorders
- Respiratory Care
Background:
- Spinal muscular atrophy (SMA) type 1 is a severe genetic disorder affecting motor neurons, leading to progressive muscle weakness and respiratory failure.
- Tracheostomy has been a common intervention for respiratory support in SMA type 1, carrying significant risks and impacting quality of life.
Purpose of the Study:
- To evaluate the feasibility of managing SMA type 1 without tracheostomy.
- To compare the efficacy of a novel respiratory muscle aid protocol against conventional management for extubation in SMA type 1 patients.
Main Methods:
- A retrospective cohort study involving eleven infants diagnosed with SMA type 1 during respiratory failure.
- Implementation of a protocol including assisted coughing techniques and extubation criteria focused on oxygen independence.
- Post-extubation support involved nasal ventilation with positive end-expiratory pressure.
Main Results:
- The respiratory muscle aid protocol resulted in a significantly higher successful extubation rate (23/28) compared to conventional management (2/20).
- Two children achieved long-term survival without intubation, requiring 24-hour nasal ventilation.
- Six children were successfully managed at home with nocturnal nasal ventilation for an average of 30.4 months post-respiratory failure.
Conclusions:
- Tracheostomy can be avoided in some children with SMA type 1, enabling management at home with non-invasive ventilation.
- The developed protocol demonstrates a promising alternative to tracheostomy for respiratory support in SMA type 1.
- Further research may refine non-invasive respiratory strategies for SMA type 1 management.
Study Objective:
To determine whether spinal muscular atrophy (SMA) type 1 can be managed without tracheostomy and to compare extubation outcomes using a respiratory muscle aid protocol vs conventional management.
Design:
A retrospective cohort study.
Methods:
Eleven SMA type 1 children were studied during episodes of respiratory failure. Nine children required multiple intubations. Along with standard treatments, these children received manually and mechanically assisted coughing to reverse airway mucus-associated decreases in oxyhemoglobin saturation. Extubation was not attempted until, most importantly, there was no oxygen requirement to maintain oxyhemoglobin saturation greater than 94%. After extubation, all patients received nasal ventilation with positive end-expiratory pressure. Successful extubation was defined by no need to reintubate during the current hospitalization.
Results:
Two children have survived for 37 and 66 months and have never been intubated despite requiring 24-h nasal ventilation since 5 and 7 months of age, respectively. One other child underwent tracheostomy for persistent left lung collapse and inadequate home care, another for need for frequent readmission and intubation, and one child was lost to follow-up 3 months after successful extubation. The other six children have been managed at home for 15 to 59 (mean 30.4) months using nocturnal nasal ventilation after an episode of respiratory failure. The nine children were successfully extubated by our protocol 23 of 28 times. The same children managed conventionally were successfully extubated 2 of 20 times when not using this protocol (p < 0.001 by the two-tailed Fisher's Exact t Test).
Conclusion:
Although intercurrent chest colds may necessitate periods of hospitalization and intubation, tracheostomy can be avoided throughout early childhood for some children with SMA type 1.